SGCB and chronic obstructive pulmonary disease: The results showed that cGMP concentration in pulmonary arterial supernatants was also significantly reduced in patients with nonhypoxemic and hypoxemic COPD as compared with control subjects (Fig. 3B), suggesting that the bioactivity of NO on soluble guanylate cyclase (sGC) in the formation of cGMP was impaired.